Showing results (1-10 of 315) with videos related to
Sort By:
Pageof 32
Blood|April 13, 2007
The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regenerationKarsten Grote, Gustavo Salguero, Matthias Ballmaier, et al.The American Journal of Cardiology|June 24, 2003
Role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, angiotensin-converting enzyme inhibitors, cyclooxygenase-2 inhibitors, and aspirin in anti-inflammatory and immunomodulatory treatment of cardiovascular diseasesBernhard Schieffer, Helmut DrexlerCirculation Research|May 17, 2003
Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen speciesKarsten Grote, Inna Flach, Maren Luchtefeld, et al.The Journal of Biological Chemistry|October 20, 2004
Stretch-inducible expression of the angiogenic factor CCN1 in vascular smooth muscle cells is mediated by Egr-1Karsten Grote, Udo Bavendiek, Christina Grothusen, et al.Blood|January 9, 2010
Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regenerationKarsten Grote, Harald Schuett, Gustavo Salguero, et al.Thescientificworldjournal|April 26, 2011
Toll-like receptors in angiogenesisKarsten Grote, Harald Schütt, Bernhard SchiefferVascular Pharmacology|November 8, 2005
JANUS under stress--role of JAK/STAT signaling pathway in vascular diseasesKarsten Grote, Maren Luchtefeld, Bernhard SchiefferAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 24, 2004
Therapeutic effects of angiotensin (AT1) receptor antagonists: potential contribution of mechanisms other than AT1 receptor blockadeBoris Schmidt, Helmut Drexler, Bernhard SchiefferBiochemical and Biophysical Research Communications|August 14, 2003
5-Lipoxygenase is involved in the angiotensin II-induced NAD(P)H-oxidase activationMaren Luchtefeld, Helmut Drexler, Bernhard SchiefferAtherosclerosis|August 24, 2005
Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosisChristina Grothusen, Sylvia Bley, Tina Selle, et al.Pageof 32